Lappe Mark

Chief Executive Officer at Inhibrx, Inc.; 10% owner at REPROS THERAPEUTICS INC.

Sold, on record
$5.2M
Dollars the filings state
Form 4 sales
6
Latest Feb 28, 2023
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale REPROS THERAPEUTICS INC.Plan not stated
    Mar 27, 2008 2008

    Sold 302,057 shares at $9.21 ($2.8M)

    Lappe Mark, 10% owner

    Sold 11.7% of holdings ($23.8M position)2.3M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale REPROS THERAPEUTICS INC.Plan not stated
    Dec 15, 2009 +628 days

    Sold 386,100 shares at $0.69 ($265k)

    Lappe Mark, 10% owner

    Sold 12.5% of holdings ($2.1M position)2.7M shares leftFiling

  3. 3 Form 4 sale Inhibrx, Inc.Plan not stated
    Oct 17, 2022 +4689 days

    Sold 26,000 shares at $29.59 ($769k)

    Lappe Mark, Chief Executive Officer

    Sold 1% of holdings ($76.6M position)2.6M shares leftFirst sale on recordFiling

  4. 4 Form 4 sale Inhibrx, Inc.Plan not stated
    Nov 17, 2022 +31 days

    Sold 26,000 shares at $27.88 ($725k)

    Lappe Mark, Chief Executive Officer

    Sold 1% of holdings ($71.5M position)2.5M shares leftFiling

  5. 5 Form 4 sale Inhibrx, Inc.Plan not stated
    Dec 19, 2022 +32 days

    Sold 26,000 shares at $25.55 ($664k)

    Lappe Mark, Chief Executive Officer

    Sold 1% of holdings ($64.9M position)2.5M shares leftFiling

  6. 6 Form 4 sale Inhibrx, Inc.Plan not stated
    Feb 28, 2023 +71 days

    Sold 60 shares at $25.02 ($2k)

    Lappe Mark, Chief Executive Officer

    Sold 0% of holdings ($62.2M position)2.5M shares left0x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (6)

Form 144 notices and Form 4 sales by Lappe Mark
Source
Feb 28, 2023Mar 1, 2023Inhibrx, Inc.Chief Executive OfficerForm 4 sale60$2k0.0%Plan not statedSEC
Dec 19, 2022Dec 20, 2022Inhibrx, Inc.Chief Executive OfficerForm 4 sale26,000$664k1.0%Plan not statedSEC
Nov 17, 2022Nov 18, 2022Inhibrx, Inc.Chief Executive OfficerForm 4 sale26,000$725k1.0%Plan not statedSEC
Oct 17, 2022Oct 18, 2022Inhibrx, Inc.Chief Executive OfficerForm 4 sale26,000$769k1.0%Plan not statedSEC
Dec 15, 2009Dec 15, 2009REPROS THERAPEUTICS INC.10% ownerForm 4 sale386,100$265k12.5%Plan not statedSEC
Mar 27, 2008Jul 3, 2008REPROS THERAPEUTICS INC.10% ownerForm 4 sale302,057$2.8M11.7%Plan not statedSEC